Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
RLMD:NASDAQ
Relmada Therapeutics Inc
$7.21
-0.55%
(-0.040) 1D
$7.21
0.00% (0.00)
Pre-market
Closed: Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLMD...
Open
$7.26
High
$7.27
Low
$6.98
Mkt. cap
756.24M
Avg. vol.
1.56M
Volume
0.00
52-wk high
$7.94
52-wk low
$0.27
EPS
-$1.45
Beta
0.44
Shares outstanding
104.89M
No. of employees
17
News stories
From sources across the web
About Relmada Therapeutics Inc
CEO-
Employees17
Founded2004
HeadquartersCoral Gables, Florida, United States
SectorPharmaceutical industry
Last report
Nov 10, 2022
Fiscal Period
Q3 2022
Normalized EPS / Estimate
-1.31/ (-1.47 est.)USD
+10.88%beat
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q3 2022 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.95M
2.82M
4.04M
5.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.27M
7.40M
6.29M
12.26M
Operating expense
18.22M
10.22M
10.33M
17.43M
Total operating expenses
18.22M
10.22M
10.33M
17.43M
Operating income
-18.22M
-10.22M
-10.33M
-17.43M
Other non operating income
-
-
-
-
EBT including unusual items
-17.56M
-9.87M
-10.09M
-19.87M
EBT excluding unusual items
-17.78M
-9.90M
-10.08M
-17.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.56M
-9.87M
-10.09M
-19.87M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
440.29K
321.46K
247.01K
387.23K
Interest expense
-
-
-
-
Net interest expenses
440.29K
321.46K
247.01K
387.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more